9 月302024

Viscometer vs Rheometer: Discover Why a Rheometer Offers More Than Just Viscosity Measurement

Polymers, 流變學

If you’re working with materials that can be flowed, for example within pharmaceutical, food, cosmetics, or petrochemical industries, it’s likely that there is a viscometer in the laboratory that is the go-to instrument for formulation testing or QA purposes. However, does this viscometer give you the whole picture and fully meet all your needs?

Details
9 月232024

What Your Material Specification Sheet Doesn’t Tell You

Mechanical Testing, Polymers, Thermal Analysis

When it comes to selecting materials for your next innovative product, the material specification sheet is likely the first place that you will turn. This document provides core properties measured by the manufacturer and serves as an essential tool for supplier verification and new product development. However, while these sheets are reliable and provide a standard method for comparison, they often fail to tell the whole story.

Details
9 月92024

Linear Viscoelastic Region: Why It’s Crucial in Materials Testing

Engineered Materials, Mechanical Testing, Pharmaceuticals, Polymers, 流變學, 食品

Our world is brimming with viscoelastic materials: The dough you knead before baking a fresh loaf, the Silly Putty your toddler slaps against the wall, the rubber gaskets that create an airtight seal on an airplane door. Testing those materials by applying controlled deformations (strains) or forces (stresses) at various timescales, temperatures, and/or humidities allows for the optimization of properties and ensures durability and safety.

Details
8 月192024

Blog-Antibody Comparison Image

Why DSC Testing is a Critical Step in Developing Biosimilar Drugs

Microcalorimetry, 生物製藥

Biologic therapies derived from living organisms have revolutionized the treatment of complex diseases, yet their high development costs are often passed onto patients. Biosimilar drugs offer a promising solution to reduce costs while maintaining therapeutic efficacy. Unlike generic drugs, biosimilars cannot be exact replicas of their reference biologics due to their complex structures, necessitating rigorous testing and regulatory approval.

Details